ELZA-sub400 protocol

ELZA researchers report 12-month outcomes for a second-generation sub400 cross-linking protocol that extends CXL to ultra-thin keratoconus and post-LASIK ectasia corneas below 400 micrometres, halting progression in 76% of eyes while shortening treatment to about 18 minutes.
A new publication in JRS reports the long-term endothelial safety of the ELZA-sub400 protocol for treating progressive keratoconus in corneas thinner than 400 µm.